UK-based biotechnology company ILC Therapeutics has announced that it has secured significant investment from its first global investor Medical Incubator Japan. The Scottish life sciences company, which has received international attention through its work exploring COVID-19 therapeutic treatments with the University of St Andrews, is MIJ’s first investment in a biotech company in Europe.